Canandaigua National Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.93M Buy
+27,540
New +$5.93M 0.58% 36
2025
Q4
$6.5M Sell
28,464
-857
-3% -$195K 0.58% 35
2025
Q3
$6.79M Sell
29,321
-1,617
-5% -$329K 0.6% 35
2025
Q2
$5.74M Buy
30,938
+422
+1% +$78.4K 0.53% 41
2025
Q1
$6.39M Sell
30,516
-1,098
-3% -$213K 0.64% 35
2024
Q4
$5.62M Sell
31,614
-497
-2% -$91.4K 0.55% 37
2024
Q3
$6.34M Sell
32,111
-847
-3% -$158K 0.6% 38
2024
Q2
$5.65M Buy
32,958
+1,823
+6% +$302K 0.61% 34
2024
Q1
$5.67M Sell
31,135
-989
-3% -$170K 0.84% 24
2023
Q4
$4.98M Sell
32,124
-1,608
-5% -$234K 0.77% 32
2023
Q3
$5.03M Buy
33,732
+5,696
+20% +$836K 0.81% 31
2023
Q2
$3.78M Sell
28,036
-442
-2% -$64.8K 0.61% 42
2023
Q1
$4.54M Buy
+28,478
New +$4.35M 0.76% 33
2020
Q1
$2.42M Sell
31,824
-269
-0.8% -$22.9K 0.51% 59
2019
Q4
$2.84M Sell
32,093
-991
-3% -$82.3K 0.48% 64
2019
Q3
$2.5M Buy
33,084
+1,900
+6% +$130K 0.44% 64
2019
Q2
$2.27M Buy
31,184
+245
+0.8% +$19.3K 0.42% 66
2019
Q1
$2.49M Sell
30,939
-8,105
-21% -$663K 0.48% 63
2018
Q4
$3.6M Sell
39,044
-820
-2% -$72.1K 0.76% 33
2018
Q3
$3.77M Buy
39,864
+1,673
+4% +$159K 0.67% 38
2018
Q2
$3.54M Buy
38,191
+2,238
+6% +$219K 0.68% 41
2018
Q1
$3.4M Buy
35,953
+2,212
+7% +$243K 0.43% 60
2017
Q4
$3.26M Sell
33,741
-231
-0.7% -$21.8K 0.59% 48
2017
Q3
$3.02M Sell
33,972
-970
-3% -$73.8K 0.57% 50
2017
Q2
$2.53M Buy
34,942
+582
+2% +$39.1K 0.52% 54
2017
Q1
$2.24M Sell
34,360
-667
-2% -$41.9K 0.66% 41
2016
Q4
$2.19M Buy
35,027
+1,252
+4% +$76.4K 0.66% 39
2016
Q3
$2.13M Sell
33,775
-817
-2% -$52.9K 0.62% 43
2016
Q2
$2.14M Buy
34,592
+1,596
+5% +$97.3K 0.61% 44
2016
Q1
$1.89M Buy
32,996
+9,949
+43% +$555K 0.55% 47
2015
Q4
$1.36M Buy
23,047
+514
+2% +$29.6K 0.42% 70
2015
Q3
$1.23M Buy
22,533
+530
+2% +$34.5K 0.39% 75
2015
Q2
$1.48M Buy
22,003
+1,832
+9% +$120K 0.43% 63
2015
Q1
$1.18M Buy
20,171
+705
+4% +$42.6K 0.35% 75
2014
Q4
$1.27M Buy
19,466
+171
+0.9% +$10.8K 0.41% 70
2014
Q3
$1.11M Buy
19,295
+545
+3% +$30.3K 0.37% 72
2014
Q2
$1.06M Sell
18,750
-341
-2% -$17.9K 0.35% 73
2014
Q1
$981K Sell
19,091
-566
-3% -$28.6K 0.33% 75
2013
Q4
$1.04M Sell
19,657
-100
-0.5% -$4.92K 0.37% 67
2013
Q3
$884K Buy
19,757
+185
+0.9% +$8.2K 0.34% 75
2013
Q2
$809K Buy
+19,572
New +$856K 0.32% 78

Other funds holding ABBV

Canandaigua National Bank & Trust's ABBV Position: Q2 2026 in Review

Canandaigua National Bank & Trust opened a new position in AbbVie (ABBV) in Q2 2026: 27,540 shares worth $6.93M. The stake represents 0.58% of the portfolio and ranks #36 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in ABBV as recently as Q4 2025.

Canandaigua National Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Canandaigua National Bank & Trust held 27,540 shares of AbbVie worth $6.93M as of Q2 2026.
  • AbbVie was a new Canandaigua National Bank & Trust position in Q2 2026.
  • AbbVie made up 0.58% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #36 holding.
  • Canandaigua National Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.